Skip to content
ClinCalc Pro
Menu
Opioid Analgesic (Ultra-Potent)

Sufentanil

Brand names: Sufenta, Dsuvia (sublingual)

Sufentanil is a potent synthetic opioid used for analgesia during anaesthesia and, in some settings, for neuraxial and acute pain management.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a highly potent selective mu-opioid receptor agonist, producing profound analgesia and dose-dependent central nervous system depression.

Prescribing in practice

  • Owing to its high potency it causes profound dose-dependent respiratory depression and must be used only where airway management and ventilatory support are immediately available.
  • Effects, including respiratory depression, are potentiated by other central nervous system depressants and can outlast a single opioid antagonist dose, requiring continued observation.
  • It can cause bradycardia, hypotension and muscle rigidity, particularly with rapid administration.

Monitoring

Continuous monitoring of respiration, oxygenation and haemodynamics is required during and after administration.

Counselling the patient

  • This is a very potent opioid given by trained anaesthetic staff with close monitoring.
  • Drowsiness and slowed breathing can occur and are watched for closely.

Evidence & guidelines

Its high potency and use as an opioid analgesic in anaesthesia are well established and described in the SPC.

Reference: OAA Guidelines on Labour Analgesia; Miller's Anaesthesia 9th Ed; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.